Vikas Gupta

18.9k total citations · 2 hit papers
96 papers, 3.0k citations indexed

About

Vikas Gupta is a scholar working on Epidemiology, Applied Microbiology and Biotechnology and Molecular Medicine. According to data from OpenAlex, Vikas Gupta has authored 96 papers receiving a total of 3.0k indexed citations (citations by other indexed papers that have themselves been cited), including 52 papers in Epidemiology, 36 papers in Applied Microbiology and Biotechnology and 27 papers in Molecular Medicine. Recurrent topics in Vikas Gupta's work include Antibiotic Use and Resistance (36 papers), Antibiotic Resistance in Bacteria (27 papers) and Urinary Tract Infections Management (24 papers). Vikas Gupta is often cited by papers focused on Antibiotic Use and Resistance (36 papers), Antibiotic Resistance in Bacteria (27 papers) and Urinary Tract Infections Management (24 papers). Vikas Gupta collaborates with scholars based in United States, India and United Kingdom. Vikas Gupta's co-authors include Ying P. Tabak, Andrew F. Shorr, Marin H. Kollef, Larry Z. Liu, R.S. Johannes, Kalvin Yu, Gang Ye, Aaron Killian, Richard S. Johannes and Benjamin A. Lipsky and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Clinical Infectious Diseases.

In The Last Decade

Vikas Gupta

84 papers receiving 2.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Epidemiology and Outcomes of Health-care–Associated Pneumonia

2005 721 citations Marin H. Kollef, Andrew F. Shorr et al. CHEST Journal profile →
Trends in Disease Severity and Health Care Utilization During the Early Omicron Variant Period Compared with Previous SARS-CoV-2 High Transmission Periods — United States, December 2020–January 2022

2022 301 citations Vikas Gupta et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Vikas Gupta United States	26	1.3k	927	652	613	574	96	3.0k
Lindsey M. Weiner United States	14	996 0.8×	822 0.9×	623 1.0×	780 1.3×	705 1.2×	23	3.1k
Alexandre R. Marra Brazil	36	1.2k 0.9×	1.6k 1.7×	561 0.9×	491 0.8×	526 0.9×	164	3.5k
Emine Alp Türkiye	30	1.1k 0.9×	682 0.7×	434 0.7×	815 1.3×	330 0.6×	145	3.1k
Kurt Stevenson United States	32	1.3k 1.0×	950 1.0×	588 0.9×	355 0.6×	738 1.3×	93	3.8k
Koenraad Vandewoude Belgium	23	1.4k 1.1×	1.0k 1.1×	664 1.0×	306 0.5×	419 0.7×	34	2.8k
Alessandro Russo Italy	29	1.2k 0.9×	961 1.0×	320 0.5×	810 1.3×	473 0.8×	136	2.9k
Paula Ramírez Spain	30	1.7k 1.3×	868 0.9×	871 1.3×	358 0.6×	387 0.7×	121	3.0k
Surbhi Leekha United States	27	951 0.7×	874 0.9×	298 0.5×	335 0.5×	582 1.0×	115	2.6k
Gennaro De Pascale Italy	31	1.2k 1.0×	923 1.0×	698 1.1×	1.0k 1.7×	643 1.1×	112	3.3k
E. Yoko Furuya United States	29	902 0.7×	730 0.8×	323 0.5×	598 1.0×	569 1.0×	84	2.7k

Countries citing papers authored by Vikas Gupta

Since Specialization

Citations

This map shows the geographic impact of Vikas Gupta's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vikas Gupta with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vikas Gupta more than expected).

Fields of papers citing papers by Vikas Gupta

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vikas Gupta. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vikas Gupta. The network helps show where Vikas Gupta may publish in the future.

Co-authorship network of co-authors of Vikas Gupta

This figure shows the co-authorship network connecting the top 25 collaborators of Vikas Gupta. A scholar is included among the top collaborators of Vikas Gupta based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vikas Gupta. Vikas Gupta is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Atenafu, Eshetu G., Steven M. Chan, Karen Yee, et al.. (2025). Identifying Risk Factors and Outcome for CNS Involvement in AML. Clinical Lymphoma Myeloma & Leukemia. 25(10). e834–e843.

Gupta, Vikas, et al.. (2024). Method Optimization and Validation of Antibiotics Residues in Milk Sample Using LC-MS/MS. Egyptian Journal of Veterinary Science. 0(0). 1–12.

Mohanty, Salini, Nicole Cossrow, Kalvin Yu, et al.. (2024). Clinical and economic burden of invasive pneumococcal disease and noninvasive all-cause pneumonia in hospitalized US adults: A multicenter analysis from 2015 to 2020. International Journal of Infectious Diseases. 143. 107023–107023. 7 indexed citations

Mohanty, Salini, Nicole Cossrow, Meghan White, et al.. (2024). Burden of invasive pneumococcal disease, non-invasive all-cause pneumonia, and acute otitis media in hospitalized US children: a retrospective multi-center study from 2015 to 2020. BMC Health Services Research. 24(1). 1574–1574. 1 indexed citations

Yu, Kalvin, Gang Ye, Jonathan R. Edwards, et al.. (2023). Treated, hospital-onset Clostridiodes difficile infection: An evaluation of predictors and feasibility of benchmarking comparing 2 risk-adjusted models among 265 hospitals. Infection Control and Hospital Epidemiology. 45(1). 48–56. 2 indexed citations

Mohanty, Salini, et al.. (2023). Trends inStreptococcus pneumoniaeAntimicrobial Resistance in US Children: A Multicenter Evaluation. Open Forum Infectious Diseases. 10(3). ofad098–ofad098. 19 indexed citations

Bauer, Karri A., Laura Puzniak, Kalvin Yu, et al.. (2023). Association of SARS-CoV-2 status and antibiotic-resistant bacteria with inadequate empiric therapy in hospitalized patients: a US multicenter cohort evaluation (July 2019 - October 2021). BMC Infectious Diseases. 23(1). 490–490. 4 indexed citations

Dunne, Michael W., Sailaja Puttagunta, Steven I. Aronin, et al.. (2022). Impact of Empirical Antibiotic Therapy on Outcomes of Outpatient Urinary Tract Infection Due to Nonsusceptible Enterobacterales. Microbiology Spectrum. 10(1). e0235921–e0235921. 26 indexed citations

Bauer, Karri A., Laura Puzniak, Kalvin Yu, et al.. (2022). Epidemiology and outcomes of culture-positive bloodstream pathogens prior to and during the SARS-CoV-2 pandemic: a multicenter evaluation. BMC Infectious Diseases. 22(1). 841–841. 13 indexed citations

10.

Aronin, Steven I., et al.. (2022). Increased rates of extended-spectrum beta-lactamase isolates in patients hospitalized with culture-positive urinary Enterobacterales in the United States: 2011 – 2020. Diagnostic Microbiology and Infectious Disease. 103(4). 115717–115717. 10 indexed citations

11.

Puzniak, Laura, Vikas Gupta, Kalvin Yu, Gang Ye, & Kevin Outterson. (2021). The impact of infections on reimbursement in 92 US hospitals, 2015-2018. American Journal of Infection Control. 49(10). 1275–1280. 4 indexed citations

12.

Puzniak, Laura, Lyn Finelli, Kalvin Yu, et al.. (2021). A multicenter analysis of the clinical microbiology and antimicrobial usage in hospitalized patients in the US with or without COVID-19. BMC Infectious Diseases. 21(1). 227–227. 23 indexed citations

13.

Gupta, Vikas, et al.. (2020). Leprosy (Hansen Disease). StatPearls. 2 indexed citations

14.

Tabak, Ying P., et al.. (2018). Attributable clinical and economic burden of carbapenem-non-susceptible Gram-negative infections in patients hospitalized with complicated urinary tract infections. Journal of Hospital Infection. 102(1). 37–44. 28 indexed citations

15.

Shorr, Andrew F., Ying P. Tabak, Richard S. Johannes, et al.. (2011). Burden of Sodium Abnormalities in Patients Hospitalized for Heart Failure. Congestive Heart Failure. 17(1). 1–7. 37 indexed citations

16.

Shorr, Andrew F., Marya D. Zilberberg, Xiaowu Sun, et al.. (2011). Severe acute hypertension among inpatients admitted from the emergency department. Journal of Hospital Medicine. 7(3). 203–210. 10 indexed citations

17.

Tabak, Ying P., Xiaowu Sun, Richard S. Johannes, Vikas Gupta, & Andrew F. Shorr. (2009). Mortality and Need for Mechanical Ventilation in Acute Exacerbations of Chronic Obstructive Pulmonary Disease. Archives of Internal Medicine. 169(17). 1595–602. 88 indexed citations

18.

Shorr, Andrew F., et al.. (2006). Morbidity and cost burden of methicillin-resistant Staphylococcus aureus in early onset ventilator-associated pneumonia. Critical Care. 10(3). R97–R97. 130 indexed citations

19.

Kollef, Marin H., Andrew F. Shorr, Ying P. Tabak, et al.. (2005). Epidemiology and Outcomes of Health-care–Associated Pneumonia. CHEST Journal. 128(6). 3854–3862. 721 indexed citations breakdown →

20.

Shorr, Andrew F., Ying P. Tabak, Vikas Gupta, et al.. (2004). The Burden of Methicillin Resistant Staphylococcus aureus in Ventilator-Associated Pneumonia. CHEST Journal. 126(4). 716S–716S.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact